latest news releases from the newsroom
Micronic Announces Laser Pattern Generator for New Generation Plasma Display Panels
TABY, Sweden, Dec. 19, 2002 (PRIMEZONE) -- Micronic Laser Systems AB (Stockholm:MICR) (Other OTC:MICLF), a leading manufacturer of laser pattern generation equipment for the semiconductor and display industries, today introduced a new laser pattern generator designed to meet the new requirements for plasma display panels (PDP). The Micronic MP185+ is the first pattern generator to address the market for the new generation of PDPs, and is capable of producing photomasks up to 1400 by 1850 mm. The system will be used to manufacture chrome PDP photomasks in volume production and R&D.
The Precondition for Proha Convertible Loan Subscription Undertaking has Been Met
HELSINKI, Finland, Dec. 19, 2002 (PRIMEZONE) -- Mr. Pekka Pere, President and CEO of Proha Plc has undertaken to subscribe for the Proha Plc convertible loan (the Loan) with EUR 1,405,000 through a company fully-owned by Mr. Pere, thus meeting with the precondition of the Loan set by Pohjola Non-Life Insurance Company Ltd. The Loan is proposed by the Board of Directors of Proha Plc to the Extraordinary General Meeting to be convened on December 20, 2002.
Stockholmsborsen: Review of Most Traded and ATTRACT40
STOCKHOLM, Sweden, Dec, 19, 2002 (PRIMEZONE) -- Stockholmsborsen's segment for the most traded shares will be updated from January 1, 2003. The Most Traded-segment (Mest omsatta) on the A-list will lose 2 companies while Attract40(TM) will get 8 new companies and 10 companies will leave the segment. The companies that leave the segments will be listed among the other companies at the A-list or the O-list segments.
SCA Invests for Increased Competitiveness
STOCKHOLM, Sweden, Dec. 19, 2002 (PRIMEZONE) -- SCA is carrying out investments to increase competitiveness in the Swedish sawmill operations and German packaging operations.
Akzo Nobel and Organon Considering Next Moves Following Adverse Summary Judgement Ruling in Remeron Lawsuit Against Generics
ARNHEM, The Netherlands and WEST ORANGE, N.J., Dec. 19, 2002 (PRIMEZONE) -- Akzo Nobel (Nasdaq:AKZOY) and Organon Inc. confirm that the U.S. Federal District Court in Newark, NJ, has granted summary judgement on non-infringement in favor of Teva Pharmaceuticals USA, Inc. and Mylan Pharmaceutical Inc. in the patent infringement lawsuit concerning Remeron(R) tablets. Akzo Nobel and Organon are studying the court's ruling to determine their next course of action. The lawsuit against Teva and Mylan alleges infringement of a patent covering the use of the antidepressant Remeron (mirtazapine) in combination with one or more SSRIs (selective serotonin reuptake inhibitors) for the treatment of depression.